MACS provides support to Maryland prescribers and their practices in addressing the needs of their patients with substance use disorders and chronic pain management.
As the pandemic ushered in isolation and financial hardship, overdose deaths reached new heights
"The pandemic has ushered in stress, isolation, and economic upheaval — all known triggers for addiction and relapse — while robbing many people of treatment options and support systems. "Read more...
Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19
“The expansion of methadone and buprenorphine use has contributed to improved treatment for OUD within a medical model... Yet the 'medicalization' of OUD treatment is situated in a long history of differential marketing and access along racial lines.” This article presents three guidelines to address racial disparities in OUD care including increasing the number of buprenorphine prescribers.Read more...
Action item: Register for our upcomingwaiver trainingto increase access to life-saving treatment for opioid use disorder.
Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults
This study examined differences in substance use between adults who identify as transgender and those who identify as cisgender while considering critical factors such as trauma and discrimination. Read more...
HOLIDAYS | The MACS line will be closed:
Monday, May 31 - Memorial Day
#MACSpotlight - February
Get to know the MACS team!
Each month we will feature a MACS team member in the #MACSpotlight.
Follow us on social media for the next #MACSpotlight on Friday, 3/19.
